- Home
- GLPG vs ETV Comparison
GLPG vs ETV Comparison
Compare GLPG & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- ETV
- Stock Information
- Founded
- GLPG 1999
- ETV 2005
- Country
- GLPG Belgium
- ETV United States
- Employees
- GLPG N/A
- ETV N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- ETV Investment Managers
- Sector
- GLPG Health Care
- ETV Finance
- Exchange
- GLPG Nasdaq
- ETV Nasdaq
- Market Cap
- GLPG 1.8B
- ETV 1.4B
- IPO Year
- GLPG 2005
- ETV N/A
- Fundamental
- Price
- GLPG $26.86
- ETV $13.39
- Analyst Decision
- GLPG Sell
- ETV
- Analyst Count
- GLPG 4
- ETV 0
- Target Price
- GLPG $25.33
- ETV N/A
- AVG Volume (30 Days)
- GLPG 489.3K
- ETV 252.5K
- Earning Date
- GLPG 04-23-2025
- ETV 01-01-0001
- Dividend Yield
- GLPG N/A
- ETV 8.75%
- EPS Growth
- GLPG N/A
- ETV N/A
- EPS
- GLPG N/A
- ETV N/A
- Revenue
- GLPG $311,493,731.00
- ETV N/A
- Revenue This Year
- GLPG $0.78
- ETV N/A
- Revenue Next Year
- GLPG N/A
- ETV N/A
- P/E Ratio
- GLPG N/A
- ETV N/A
- Revenue Growth
- GLPG 18.32
- ETV N/A
- 52 Week Low
- GLPG $22.36
- ETV $11.05
- 52 Week High
- GLPG $31.23
- ETV $13.50
- Technical
- Relative Strength Index (RSI)
- GLPG 58.65
- ETV 58.84
- Support Level
- GLPG $24.74
- ETV $13.16
- Resistance Level
- GLPG $27.81
- ETV $13.58
- Average True Range (ATR)
- GLPG 0.78
- ETV 0.19
- MACD
- GLPG 0.00
- ETV 0.08
- Stochastic Oscillator
- GLPG 69.06
- ETV 77.84
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.